HeartSciences Inc. HSCS
NASDAQ
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.28% | 59.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.96% | 31.49% | |||
| Operating Income | -15.88% | -31.49% | |||
| Income Before Tax | -15.32% | -38.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.32% | -38.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.32% | -38.57% | |||
| EBIT | -15.88% | -31.49% | |||
| EBITDA | -15.94% | -31.61% | |||
| EPS Basic | 1.26% | -39.47% | |||
| Normalized Basic EPS | 1.24% | -39.45% | |||
| EPS Diluted | 1.26% | -39.47% | |||
| Normalized Diluted EPS | 1.24% | -39.45% | |||
| Average Basic Shares Outstanding | 16.78% | -0.65% | |||
| Average Diluted Shares Outstanding | 16.78% | -0.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||